SUMMARY

This is Purdue, the official podcast for Purdue University, highlights stories about Boilermakers from across all disciplines, who through research, innovation and determination, have persistently pursued their next giant leap.

Hosted by Purdue University alum, Brian Lamb School of Communication graduate, and Indiana native Kate Young, This is Purdue aims to examine all of the incredible accomplishments of Boilermakers and their contributions to the world.

Below, you’ll find helpful information, stories, and social media content regarding this episode of This is Purdue.

STRATEGY

In this episode of “This Is Purdue,” we’re featuring a Boilermaker whose innovations are changing and saving lives across the world.

Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.

Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)

RESOURCES INCLUDE:

• Links to the podcast
• Social graphics
• Suggested social post copy

LINKS and UTM PARAMETERS

When linking to Purdue websites from social platforms or emails, it is recommended that UTM parameters be added to the URL in order to provide reporting on the activity. The Marketing and Communications campaign URL builder allows you to easily configure these links and even request shortened Purdue-branded links.

UTM Campaign: this_is_purdue_phil_low_cancer_drug

UTM Medium: Social (or email)

UTM Source: Facebook, Twitter, LinkedIn, Instagram (or email newsletter name)

Links to the podcast:

Episode 49 Podcast Page: https://stories.purdue.edu/podcast/purdue-discovered-drug-strengthens-fight-against-cancer/

Podcast Page on Purdue.edu –  https://www.purdue.edu/podcast/

Apple – https://podcasts.apple.com/us/podcast/this-is-purdue/id1496040232

Spotify – https://open.spotify.com/show/1npQBIaTzFnCvDlzeiNV7j?si=h0K1NkdwTMeu-MlzckGaHw

AVAILABLE ASSETS

The following assets are available for download and use.  Social assets include files for Twitter, Facebook, LinkedIn, Instagram and Instagram Stories.

SOCIAL MEDIA GUIDANCE

POSTING TIPS

Digital engagement is a powerful platform to share Purdue stories and posts with past, present and future Boilermakers. Here are some tips to help your posts shine.

• Keep posts short and direct
• Link all posts back to our landing page
• Include photos, videos, or GIF’s
• Use short URLS

SUGGESTED SOCIAL MEDIA POSTS

LinkedIn + Facebook

1. A NEW episode of #ThisIsPurdue is out now! Purdue professor and researcher Philip Low is changing lives with a new drug used in ovarian cancer surgeries. Listen in as Professor Low discusses how the recently FDA-approved drug called Cytalux works, why the team started using this drug on ovarian cancer patients first, and what attracted him to the innovation happening at #Purdue. (Hint: He’s been a #Boilermaker since birth!) <link>
2. #Purdue professor and researcher Philip Low is making the world a better place through his giant leap in ovarian cancer research. Professor Low and his team developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery. Listen in to the latest episode of #ThisIsPurdue to discover more: <link>
3. #Purdue researcher and professorPhilip Low has been a #Boilermaker since birth. Listen in to #ThisIsPurdue to hear more about his life growing up in West Lafayette and why he’s an avid @PurdueFootball and @BoilerBall fan. Plus, you’ll hear about Professor Low’s recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery. <link>
4. How will you make a difference in the world? Purdue professor and researcher Philip Low is making his difference through innovation in ovarian cancer treatment. Listen in to the latest episode of #ThisIsPurdue to hear Professor Low discuss his development of Cytalux, the recently FDA-approved drug that helps illuminate cancer cells during surgery. <link>

Twitter + Instagram

1. A NEW episode of #ThisIsPurdue is out now! Listen in as @PurdueScience Professor Philip Low discusses the #Purdue-developed drug that is changing the lives of ovarian cancer patients. You don’t want to miss this conversation. <link>
2. #Purdue Professor Philip Low is making the world a better place through his giant leap in ovarian cancer research. Listen in to the latest episode of #ThisIsPurdue to learn more about the recently FDA-approved drug that Prof. Low helped develop: <link>
3. .@purduescience Prof Philip Low has been a #Boilermaker since birth. Listen in to #ThisIsPurdue to hear more about his life growing up in West Lafayette and why he’s an avid @PurdueFootball and @BoilerBall fan. <link>
4. How will you make a difference in the world? Purdue professor and researcher Philip Low is making his difference through innovation in ovarian cancer treatment. Listen to the latest episode of #ThisIsPurdue to learn more: <link>

TAGGING RECOMMENDATIONS

Please tag Purdue University and use the hashtag #ThisIsPurdue

Facebook: @PurdueUniversity
Twitter: @lifeatpurdue
Instagram: @lifeatpurdue

Other tagging options on Twitter include:

@PurdueScience

CAMPAIGN SPECIFIC HASHTAGS

#ThisIsPurdue

CAMPUSWIDE HASHTAGS

#PurdueUniversity

#MySmallStep = Student stories

#MyGiantLeap = Faculty/Alumni stories

EMOJIS
🎧🚂🆙